US4603112A
(en)
*
|
1981-12-24 |
1986-07-29 |
Health Research, Incorporated |
Modified vaccinia virus
|
US5505941A
(en)
*
|
1981-12-24 |
1996-04-09 |
Health Research, Inc. |
Recombinant avipox virus and method to induce an immune response
|
US7767449B1
(en)
|
1981-12-24 |
2010-08-03 |
Health Research Incorporated |
Methods using modified vaccinia virus
|
US7045313B1
(en)
|
1982-11-30 |
2006-05-16 |
The United States Of America As Represented By The Department Of Health And Human Services |
Recombinant vaccinia virus containing a chimeric gene having foreign DNA flanked by vaccinia regulatory DNA
|
GB9014950D0
(en)
*
|
1990-07-06 |
1990-08-29 |
Univ Glasgow |
Ehv-4 glycoprotein vaccine
|
US5674735A
(en)
*
|
1990-07-06 |
1997-10-07 |
University Court Of The University Of Glasgow |
DNA encoding the EHV-4 gH or gC glycoprotein
|
WO1992005263A1
(en)
*
|
1990-09-25 |
1992-04-02 |
Cantab Pharmaceuticals Research Limited |
Viral defective vaccine produced by transcomplementing cell line
|
US7374768B1
(en)
*
|
1990-09-25 |
2008-05-20 |
Xenova Research Limited |
Viral vaccines
|
US5997878A
(en)
|
1991-03-07 |
1999-12-07 |
Connaught Laboratories |
Recombinant poxvirus-cytomegalovirus, compositions and uses
|
US5759552A
(en)
*
|
1991-03-07 |
1998-06-02 |
Virogenetics Corporation |
Marek's disease virus recombinant poxvirus vaccine
|
GB9105383D0
(en)
*
|
1991-03-14 |
1991-05-01 |
Immunology Ltd |
An immunotherapeutic for cervical cancer
|
EP0538496B1
(en)
*
|
1991-08-26 |
2003-10-29 |
Baxter Healthcare S.A. |
Recombinant fowlpox virus with intact FPV-tk-gene
|
EP0561034B1
(en)
|
1991-08-26 |
1999-06-09 |
IMMUNO Aktiengesellschaft |
Direct molecular cloning of a modified chordopox virus genome
|
US5869312A
(en)
*
|
1992-01-13 |
1999-02-09 |
Syntro Corporation |
Recombinant swinepox virus
|
US6136318A
(en)
*
|
1993-02-26 |
2000-10-24 |
Cochran; Mark D. |
Recombinant fowlpox viruses and uses thereof
|
US5925358A
(en)
*
|
1993-02-26 |
1999-07-20 |
Syntro Corporation |
Recombinant fowlpox viruses and uses thereof
|
AU696247B2
(en)
*
|
1993-02-26 |
1998-09-03 |
Syntro Corporation |
Recombinant fowlpox viruses and uses thereof
|
US6010703A
(en)
*
|
1993-07-26 |
2000-01-04 |
Board Of Trustees Operating Michigan State University |
Recombinant poxvirus vaccine against feline rhinotracheitis
|
WO1995026751A1
(en)
*
|
1994-03-30 |
1995-10-12 |
Virogenetics Corporation |
NUCLEOTIDE AND AMINO ACID SEQUENCES OF CANINE HERPESVIRUS gB, gC and gD AND USES THEREFOR
|
WO1995030018A2
(en)
*
|
1994-04-29 |
1995-11-09 |
Immuno Aktiengesellschaft |
Recombinant poxviruses with foreign polynucleotides in essential regions
|
AU737243B2
(en)
|
1996-07-03 |
2001-08-16 |
Merial, Inc. |
Recombinant canine adenovirus (CAV) containing exogenous DNA
|
US6183752B1
(en)
*
|
1997-02-05 |
2001-02-06 |
Pasteur Merieux Serums Et Vaccins |
Restenosis/atherosclerosis diagnosis, prophylaxis and therapy
|
US6517843B1
(en)
|
1999-08-31 |
2003-02-11 |
Merial |
Reduction of porcine circovirus-2 viral load with inactivated PCV-2
|
US6224882B1
(en)
|
1997-11-07 |
2001-05-01 |
Protein Science Corp. |
Insect cells or fractions as adjuvant for antigens
|
ES2315008T5
(es)
|
1998-02-24 |
2012-03-06 |
Sisters Of Providence In Oregon |
Agente de unión a receptor ox-40 para su uso en métodos de mejora de la respuesta inmune espec�?fica de ant�?geno tumoral.
|
BR9908267A
(pt)
|
1998-02-27 |
2000-10-24 |
Univ Pennsylvania |
Plasmìdeo, composição farmacêutica, processos para induzir uma resposta imunológica em um indivìduo contra um imunógeno, para imunizar um indivìduo contra uma infecção por vìrus de herpes simples e para tratar um indivìduo que tem uma doença autoimune, vacina recombinante, e, patógeno atenuado vivo
|
AU3498200A
(en)
|
1999-02-19 |
2000-09-04 |
Michigan State University |
An antigen test to detect equine protozoal myeloencephalitis in horse serum and cerebrospinal fluid
|
BR0008645A
(pt)
|
1999-03-03 |
2002-01-22 |
Univ Pennsylvania |
Métodos de induzir uma resposta imunológica contra um imunógeno em um indivìduo, de reduzir rejeição de células, tecido ou órgão doadores nã0-assemelhados em um indivìduo e uma resposta imunológica dominante em um indivìduo e de expandir uma subpopulação de células t associadas com uma resposta imunológica especìfica, plasmìdeo, e, composição
|
WO2000066162A1
(en)
|
1999-04-30 |
2000-11-09 |
The Trustees Of The University Of Pennsylvania |
Mutant human cd80 and compositions for and methods of making and using the same
|
CA2375320C
(en)
*
|
1999-06-10 |
2013-02-19 |
Merial |
Dna vaccines for pets or for animals used in sports
|
WO2000076538A1
(en)
|
1999-06-10 |
2000-12-21 |
Michigan State University |
Feline calicivirus isolated from cat urine and vaccines thereof
|
CA2382026A1
(en)
|
1999-09-02 |
2001-03-08 |
Ruth A. Vrable |
Vaccine to control equine protozoal myeloencephalitis in horses
|
US7419668B1
(en)
|
1999-09-02 |
2008-09-02 |
Board Of Trustees Of Michigan State University |
Vaccine to control equine protozoal myeloencephalitis in horses
|
DE60038048T2
(de)
*
|
1999-12-21 |
2009-07-09 |
Merial |
Mindestens ein cryptosporidium parvum-antigen und mindestens ein antigen eines anderen darmkrankheitserregers enthaltende zusammensetzungen und impfstoffe
|
CN1312171C
(zh)
*
|
2000-07-14 |
2007-04-25 |
宾夕法尼亚州立大学托管会 |
可编码hiv辅助蛋白的dna疫苗
|
AU2002211490A1
(en)
*
|
2000-10-04 |
2002-04-15 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods of using capsid protein from flaviviruses and pestiviruses
|
US7628980B2
(en)
*
|
2000-11-23 |
2009-12-08 |
Bavarian Nordic A/S |
Modified vaccinia virus ankara for the vaccination of neonates
|
NZ524661A
(en)
*
|
2000-11-23 |
2005-03-24 |
Bavarian Nordic As |
Modified vaccinia ankara virus variant
|
US7097842B2
(en)
*
|
2000-11-23 |
2006-08-29 |
Bavarian Nordic A/S |
Modified vaccinia virus ankara for the vaccination of neonates
|
US20020108132A1
(en)
*
|
2001-02-02 |
2002-08-08 |
Avigenics Inc. |
Production of a monoclonal antibody by a transgenic chicken
|
US7541512B2
(en)
*
|
2001-03-30 |
2009-06-02 |
Synageva Biopharma Corp. |
Avians containing a lysozyme promoter transgene
|
EP1478751A4
(en)
*
|
2001-03-30 |
2005-10-19 |
Avigenics Inc |
LYSOZYM PROMOTER IN BIRDS
|
US7176300B2
(en)
*
|
2001-03-30 |
2007-02-13 |
Avigenics, Inc. |
Avian lysozyme promoter
|
US20040037848A1
(en)
*
|
2001-04-06 |
2004-02-26 |
Audonnet Jean-Christophe Francis |
Recombinant vaccine against West Nile Virus
|
FR2823222B1
(fr)
|
2001-04-06 |
2004-02-06 |
Merial Sas |
Vaccin contre le virus de la fievre du nil
|
US7740863B2
(en)
*
|
2001-04-06 |
2010-06-22 |
Merial |
Recombinant vaccine against West Nile Virus
|
AU2002329176A1
(en)
|
2001-05-25 |
2002-12-23 |
The Trustees Of The University Of Pennsylvania |
Targeted particles and methods of using the same
|
US7550650B2
(en)
*
|
2001-09-18 |
2009-06-23 |
Synageva Biopharma Corp. |
Production of a transgenic avian by cytoplasmic injection
|
US7294507B2
(en)
*
|
2001-11-30 |
2007-11-13 |
Avigenics, Inc. |
Ovomucoid promoters and methods of use
|
US6875588B2
(en)
|
2001-11-30 |
2005-04-05 |
Avigenics, Inc. |
Ovomucoid promoter and methods of use
|
US20100333219A1
(en)
*
|
2001-11-30 |
2010-12-30 |
Synageva Biopharma Corp. |
Methods of protein production using ovomucoid regulatory regions
|
US7335761B2
(en)
*
|
2001-11-30 |
2008-02-26 |
Avigenics, Inc. |
Avian gene expression controlling regions
|
US7135562B2
(en)
*
|
2002-03-14 |
2006-11-14 |
University Of Cincinnati |
Avian iFABP gene expression controlling region
|
US20040241723A1
(en)
*
|
2002-03-18 |
2004-12-02 |
Marquess Foley Leigh Shaw |
Systems and methods for improving protein and milk production of dairy herds
|
EP1839672A3
(en)
*
|
2002-04-19 |
2007-11-21 |
Bavarian Nordic A/S |
Modified vaccinia virus Ankara for the vaccination of neonates
|
EA007811B1
(ru)
|
2002-05-16 |
2007-02-27 |
Бавариан Нордик А/С |
Межгенные области, используемые в качестве инсерционных сайтов в геноме модифицированного вируса коровьей оспы анкара (mva)
|
KR101044538B1
(ko)
*
|
2002-09-05 |
2011-06-27 |
버베리안 노딕 에이/에스 |
무혈청 조건하에서 일차세포의 배양 및 바이러스의 증식방법
|
AU2003296974A1
(en)
*
|
2002-12-13 |
2004-07-14 |
Aventis Pasteur, Inc. |
Production of alvac on avian embryonic stem cells
|
CN1980571A
(zh)
*
|
2003-01-24 |
2007-06-13 |
阿维季尼克斯股份有限公司 |
禽类及禽蛋中表达的外源蛋白质
|
US7262027B2
(en)
*
|
2003-03-14 |
2007-08-28 |
Medical College Of Ohio |
Polypeptide and DNA immunization against Coccidioides spp. infections
|
EP1606419A1
(en)
|
2003-03-18 |
2005-12-21 |
Quantum Genetics Ireland Limited |
Systems and methods for improving protein and milk production of dairy herds
|
US7468273B2
(en)
|
2003-05-01 |
2008-12-23 |
Meial Limited |
Canine GHRH gene, polypeptides and methods of use
|
ATE535249T1
(de)
|
2003-06-13 |
2011-12-15 |
Univ Pennsylvania |
Vakzine, immuntherapeutika und verfahren zu ihrer verwendung
|
NZ570709A
(en)
|
2003-06-13 |
2010-04-30 |
Univ Pennsylvania |
Nucleic acid sequences encoding and compositions comprising IgE signal peptide and/or IL-15 and methods for using the same
|
WO2005049794A2
(en)
|
2003-11-13 |
2005-06-02 |
University Of Georgia Research Foundation, Inc. |
Methods of characterizing infectious bursal disease virus
|
ATE510928T1
(de)
|
2004-02-19 |
2011-06-15 |
Univ Alberta |
Leptinpromotor-polymorphismen und verwendungen davon
|
WO2007050095A2
(en)
|
2004-11-19 |
2007-05-03 |
The Trustees Of The University Of Pennsylvania |
Improved vaccines and methods for using the same
|
WO2006056487A2
(en)
|
2004-11-24 |
2006-06-01 |
Theraptosis S.A. |
Peptides useful as dual caspase-2/-6 inhibitors and their biological applications
|
US20080064862A1
(en)
*
|
2004-12-29 |
2008-03-13 |
Avigenics, Inc. |
Transgene expression in a avians
|
ES2343270T3
(es)
|
2005-04-25 |
2010-07-27 |
Merial Ltd. |
Vacunas contra el virus nipah.
|
ATE496629T1
(de)
*
|
2005-07-28 |
2011-02-15 |
Pfizer Prod Inc |
Impfstoff gegen felines calicivirus (fcv), der ein fcv kapsid protein oder ein isoliertes fcv kapsid protein mit der protein sequenz seq id no: 13 oder mit einer protein sequenz, die zumindestens zu 95 identisch zur seq id no: 13 ist enthält.
|
US20080241184A1
(en)
|
2005-08-25 |
2008-10-02 |
Jules Maarten Minke |
Canine influenza vaccines
|
US7771995B2
(en)
|
2005-11-14 |
2010-08-10 |
Merial Limited |
Plasmid encoding human BMP-7
|
EP3147296A1
(en)
|
2005-11-14 |
2017-03-29 |
Merial, Inc. |
Gene therapy for renal failure
|
US7745158B2
(en)
*
|
2005-12-14 |
2010-06-29 |
Kimberly-Clark Worldwide, Inc. |
Detection of secreted aspartyl proteases from Candida species
|
ATE533782T1
(de)
*
|
2006-01-13 |
2011-12-15 |
Univ Pennsylvania |
Impfstoffe und immuntherapeutika mit codon- optimiertem il-15 und verwendungsverfahren dafür
|
EP1981905B1
(en)
|
2006-01-16 |
2016-08-31 |
THE GOVERNMENT OF THE UNITED STATES OF AMERICA as represented by THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES |
Chlamydia vaccine
|
EP2019687B1
(en)
|
2006-03-29 |
2014-03-19 |
Merial Limited |
Vaccine against streptococci
|
US20090060947A1
(en)
*
|
2006-05-19 |
2009-03-05 |
Sanofi Pasteur, Inc. |
Immunological compositions
|
US7862821B2
(en)
|
2006-06-01 |
2011-01-04 |
Merial Limited |
Recombinant vaccine against bluetongue virus
|
CA3057039C
(en)
|
2006-07-28 |
2023-02-28 |
The Trustees Of The University Of Pennsylvania |
Hiv consensus envelope sequences and methods for using same
|
US8202967B2
(en)
|
2006-10-27 |
2012-06-19 |
Boehringer Ingelheim Vetmedica, Inc. |
H5 proteins, nucleic acid molecules and vectors encoding for those, and their medicinal use
|
KR101445903B1
(ko)
|
2007-05-02 |
2014-09-29 |
메리얼 리미티드 |
향상된 발현 및 안정성을 갖는 dna 플라스미드
|
TW200907058A
(en)
|
2007-05-30 |
2009-02-16 |
Wyeth Corp |
Raccoon poxvirus expressing rabies glycoproteins
|
US20090246226A1
(en)
*
|
2008-03-28 |
2009-10-01 |
Zeon Corporation |
Avian vaccines possessing a positive marker gene
|
WO2009124309A2
(en)
|
2008-04-04 |
2009-10-08 |
The Trustees Of The University Of Pennsylvania |
Vaccines and immunotherapeutics using il-28 and compositions and methods of using the same
|
KR101589511B1
(ko)
*
|
2008-04-04 |
2016-02-01 |
더 트러스티스 오브 더 유니버시티 오브 펜실바니아 |
치쿤구니야 바이러스 단백질의 공통 서열, 이를 인코딩하는 핵산 분자, 조성물 및 이를 이용하는 방법
|
ES2760004T3
(es)
|
2008-05-08 |
2020-05-12 |
Boehringer Ingelheim Animal Health Usa Inc |
Vacuna contra Leishmania utilizando un inmunnógeno salival de mosca de la arena
|
JP5753090B2
(ja)
|
2008-10-29 |
2015-07-22 |
ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア |
改良型hcvワクチンおよびその使用方法
|
US8921536B2
(en)
|
2008-10-29 |
2014-12-30 |
The Trustees Of The University Of Pennsylvania |
HCV vaccines and methods for using the same
|
CA2653478A1
(en)
*
|
2009-01-23 |
2010-07-23 |
Gregg Martin |
Automated wash system for industrial vehicles
|
US9050287B2
(en)
|
2009-01-23 |
2015-06-09 |
The Trustees Of The University Of Pennsylvania |
Vaccines for human papilloma virus and methods for using the same
|
US20100192236A1
(en)
*
|
2009-01-28 |
2010-07-29 |
University Of South Carolina |
Modulation of Delta Opioid Receptor Expression
|
CN102428099B
(zh)
|
2009-04-03 |
2016-03-16 |
梅里亚有限公司 |
运载新城疫病毒的禽疫苗
|
US20100284977A1
(en)
*
|
2009-04-28 |
2010-11-11 |
University Of South Carolina |
Expression of Anti-Nociceptive Compounds from Endogenously Regulated Promoters
|
EP2424999A1
(en)
|
2009-04-30 |
2012-03-07 |
Centre Hospitalier Universitaire Vaudois Lausanne (CHUV) |
Modified immunization vectors
|
TWI627281B
(zh)
|
2009-09-02 |
2018-06-21 |
百靈佳殷格翰家畜藥品公司 |
降低pcv-2組合物殺病毒活性之方法及具有改良免疫原性之pcv-2組合物
|
AU2010291900A1
(en)
|
2009-09-14 |
2012-03-22 |
The Trustees Of The University Of Pennsylvania |
Vaccines and immunotherapeutics comprising IL-15 receptor alpha and/or nucleic acid molecules encoding the same, and methods for using the same
|
WO2011054011A2
(en)
|
2009-11-02 |
2011-05-05 |
The Trustees Of The University Of Pennsylvania |
Foot and mouth disease virus (fmdv) consensus proteins, coding sequences therefor and vaccines made therefrom
|
US8298820B2
(en)
|
2010-01-26 |
2012-10-30 |
The Trustees Of The University Of Pennsylvania |
Influenza nucleic acid molecules and vaccines made therefrom
|
AU2011213559B2
(en)
|
2010-02-08 |
2015-05-07 |
The Trustees Of The University Of Pennsylvania |
Nucleic acid molecules encoding RANTES, and compositions comprising and methods of using the same
|
US9109007B2
(en)
|
2010-08-18 |
2015-08-18 |
Purdue Pharma L.P. |
MHC-I restricted epitopes containing non-natural amino acid residues
|
MX344103B
(es)
|
2010-08-31 |
2016-12-05 |
Merial Ltd |
Vacunas de virus herpes vectorizado con virus de enfermedad de newcastle.
|
AR083533A1
(es)
|
2010-10-22 |
2013-03-06 |
Boehringer Ingelheim Vetmed |
Proteinas de hemaglutinina 5 (h5) para el tratamiento y prevencion de las infecciones de gripe
|
ES2718846T3
(es)
|
2010-11-12 |
2019-07-04 |
Univ Pennsylvania |
Antígenos de próstata consenso, molécula de ácido nucleico que los codifica y la vacuna y usos que los comprenden
|
WO2012090073A2
(en)
|
2010-12-30 |
2012-07-05 |
The Netherlands Cancer Institute |
Methods and compositions for predicting chemotherapy sensitivity
|
KR20140007404A
(ko)
|
2011-01-31 |
2014-01-17 |
더 트러스티스 오브 더 유니버시티 오브 펜실바니아 |
신규 허피스 항원을 암호화하는 핵산 분자, 이것을 포함하는 백신 및 이것의 사용 방법
|
PL2672992T3
(pl)
|
2011-02-11 |
2020-11-02 |
The Trustees Of The University Of Pennsylvania |
Cząsteczka kwasu nukleinowego kodująca białko rdzeniowe wirusa zapalenia wątroby typu B i szczepionka je zawierająca
|
US9238679B2
(en)
|
2011-02-11 |
2016-01-19 |
The Trustees Of The University Of Pennslyvania |
Nucleic acid molecule encoding hepatitis B virus core protein and surface antigen protein and vaccine comprising the same
|
EP2694678A2
(en)
|
2011-04-04 |
2014-02-12 |
Netherland Cancer Institute |
Methods and compositions for predicting resistance to anticancer treatment
|
AU2012240240A1
(en)
|
2011-04-04 |
2013-05-09 |
Netherlands Cancer Institute |
Methods and compositions for predicting resistance to anticancer treatment with protein kinase inhibitors
|
US9216213B2
(en)
|
2011-04-20 |
2015-12-22 |
Merial, Inc. |
Adjuvanted rabies vaccine with improved viscosity profile
|
CN103945864A
(zh)
|
2011-04-25 |
2014-07-23 |
先进生物学实验室股份有限公司 |
截短的hiv包膜蛋白(env)、其相关方法和组合物
|
US9669085B2
(en)
|
2011-06-01 |
2017-06-06 |
Merial Inc. |
Needle-free administration of PRRSV vaccines
|
US9446114B2
(en)
|
2011-07-11 |
2016-09-20 |
Inovio Pharmaceuticals, Inc. |
Cross-protective arenavirus vaccines and their method of use
|
RU2591817C2
(ru)
|
2011-07-20 |
2016-07-20 |
Мериал Лимитед |
Рекомбинантная вакцина вируса лейкемии кошек, содержащая оптимизированный ген оболочки вируса лейкемии кошек
|
CN103841963B
(zh)
|
2011-08-12 |
2018-04-24 |
梅里亚股份有限公司 |
用于生物产品特别是疫苗的真空辅助保存
|
AR088028A1
(es)
|
2011-08-15 |
2014-05-07 |
Boehringer Ingelheim Vetmed |
Proteinas h5, de h5n1 para un uso medicinal
|
WO2013033092A2
(en)
|
2011-09-03 |
2013-03-07 |
Boehringer Ingelheim Vetmedica Gmbh |
Streptococcus suis pilus antigens
|
KR20220035279A
(ko)
|
2011-10-12 |
2022-03-21 |
더 트러스티스 오브 더 유니버시티 오브 펜실베니아 |
인간 파필로마 바이러스에 대한 백신 및 이것을 사용하는 방법
|
CA2851336C
(en)
|
2011-10-24 |
2021-01-12 |
The Trustees Of The University Of Pennsylvania |
Improved hcv vaccines and methods for using the same
|
MX354986B
(es)
|
2011-12-12 |
2018-03-28 |
Univ Pennsylvania |
Composiciones que comprenden construcciones geneticas y vacunas de il-12 mejoradas, agentes inmunoterapeuticos y metodos para su uso.
|
CA2858884A1
(en)
|
2011-12-12 |
2013-06-20 |
The Trustees Of The University Of Pennsylvania |
Proteins comprising mrsa pbp2a and fragments thereof, nucleic acids encoding the same, and compositions and their use to prevent and treat mrsa infections
|
WO2013093629A2
(en)
|
2011-12-20 |
2013-06-27 |
Netherlands Cancer Institute |
Modular vaccines, methods and compositions related thereto
|
WO2013138776A1
(en)
|
2012-03-16 |
2013-09-19 |
Merial Limited |
Novel methods for providing long-term protective immunity against rabies in animals, based upon administration of replication-deficient flavivirus expressing rabies g
|
BR112014023414B1
(pt)
*
|
2012-03-20 |
2022-08-30 |
Boehringer Ingelheim Animal Health USA Inc. |
Vacina de herpesvirus-1 equino recombinante contendo uma glicoproteína c mutante e seus usos
|
EP3511337A1
(en)
|
2012-04-10 |
2019-07-17 |
The Trustees of The University of Pennsylvania |
Human respiratory syncytial virus concensus antigens, nucleic acid constructs and vaccines made thereform, and methods of using same
|
WO2014127825A1
(en)
|
2013-02-21 |
2014-08-28 |
Boehringer Ingelheim Vetmedica Gmbh |
H5 proteins of h5n1 influenza virus for use as a medicament
|
EP2968514A1
(en)
|
2013-03-12 |
2016-01-20 |
Merial, Inc. |
Reverse genetics schmallenberg virus vaccine compositions, and methods of use thereof
|
EP3586870A1
(en)
|
2013-03-12 |
2020-01-01 |
The Trustees Of The University Of Pennsylvania |
Improved vaccines for human papilloma virus and methods for using the same
|
EP3756683A1
(en)
|
2013-03-15 |
2020-12-30 |
The Trustees Of The University Of Pennsylvania |
Foot and mouth disease virus (fmdv) consensus proteins, coding sequences therefor and vaccines made therefrom
|
EP3607974A1
(en)
|
2013-03-15 |
2020-02-12 |
The Trustees of The University of Pennsylvania |
Cancer vaccines and methods of treatment using the same
|
AU2015241107B2
(en)
|
2014-04-03 |
2019-10-03 |
Boehringer Ingelheim Animal Health USA Inc. |
Porcine epidemic diarrhea virus vaccine
|
NZ731659A
(en)
|
2014-11-03 |
2018-10-26 |
Merial Inc |
Methods of using microneedle vaccine formulations to elicit in animals protective immunity against rabies virus
|
PL3313864T3
(pl)
|
2015-06-23 |
2022-01-03 |
Boehringer Ingelheim Animal Health USA Inc. |
Rekombinowane wektory wirusowe zawierające drugorzędne białko prrsv oraz sposoby ich wytwarzania i zastosowania
|
ES2778649T3
(es)
|
2015-08-31 |
2020-08-11 |
Boehringer Ingelheim Vetmedica Gmbh |
Vacunas pestivirales para temblores congénitos
|
MX2018003173A
(es)
|
2015-09-16 |
2018-05-17 |
Boehringer Ingelheim Vetmedica Inc |
Vacunas de salmonella choleraesuis-salmonella typhimurium.
|
EP3515480A1
(en)
|
2016-09-20 |
2019-07-31 |
Boehringer Ingelheim Vetmedica GmbH |
New swine influenza vaccine
|
AR109540A1
(es)
|
2016-09-20 |
2018-12-19 |
Boehringer Ingelheim Vetmedica Gmbh |
Moléculas promotoras para expresar antígenos virales
|
CN109715204B
(zh)
|
2016-09-20 |
2023-08-22 |
勃林格殷格翰动物保健有限公司 |
新的ehv插入位点orf70
|
TW201823467A
(zh)
|
2016-09-20 |
2018-07-01 |
德商百靈佳殷格翰維美迪加股份有限公司 |
犬腺病毒載體
|
WO2018083154A1
(en)
|
2016-11-03 |
2018-05-11 |
Boehringer Ingelheim Vetmedica Gmbh |
Vaccine against porcine parvovirus
|
MY191895A
(en)
|
2016-11-03 |
2022-07-18 |
Boehringer Ingelheim Vetmedica Gmbh |
Vaccine against porcine parvovirus and porcine reproductive and respiratory syndrome virus and methods of production thereof
|
JP2020506915A
(ja)
|
2017-01-30 |
2020-03-05 |
ベーリンガー インゲルハイム アニマル ヘルス ユーエスエイ インコーポレイテッド |
ブタコロナウイルスワクチン
|
WO2019014144A1
(en)
|
2017-07-12 |
2019-01-17 |
Boehringer Ingelheim Vetmedica, Inc. |
IMMUNOGENIC COMPOSITIONS BASED ON SENECAVIRUS TYPE A AND CORRESPONDING METHODS
|
CA3072553A1
(en)
|
2017-09-23 |
2019-03-28 |
Boehringer Ingelheim Vetmedica Gmbh |
Paramyxoviridae expression system
|
WO2019092027A1
(en)
|
2017-11-09 |
2019-05-16 |
Boehringer Ingelheim Vetmedica Gmbh |
Sapelovirus immunogenic compositions and uses thereof
|
KR20230116954A
(ko)
|
2017-12-13 |
2023-08-04 |
이노비오 파마수티컬즈, 인크. |
Muc16을 표적화하는 암 백신 및 이의 용도
|
WO2019118760A1
(en)
|
2017-12-13 |
2019-06-20 |
Inovio Pharmaceuticals, Inc. |
Cancer vaccines targeting mesothelin and uses thereof
|
BR112020011443A2
(pt)
|
2017-12-13 |
2020-12-01 |
Inovio Pharmaceuticals, Inc. |
molécula de ácido nucleico e seu uso, vetor e seu uso, composição, proteína e vacina
|
RU2711907C2
(ru)
*
|
2017-12-22 |
2020-01-23 |
Федеральное государственное бюджетное научное учреждение "Научно-исследовательский институт вакцин и сывороток им. И.И. Мечникова" (ФГБНУ НИИВС им. И.И. Мечникова) |
Рекомбинантный белок, содержащий антигенно-значимые фрагменты белков вируса гепатита Е, используемый в тест-системах для серодиагностики гепатита Е (варианты)
|
AU2019223768A1
(en)
|
2018-02-23 |
2020-08-27 |
Boehringer Ingelheim Animal Health USA Inc. |
Recombinant viral vector systems expressing exogenous feline paramyxovirus genes and vaccines made therefrom
|
CA3091960A1
(en)
|
2018-03-19 |
2019-09-26 |
Boehringer Ingelheim Vetmedica Gmbh |
New ehv insertion site ul43
|
AR115002A1
(es)
|
2018-03-19 |
2020-11-18 |
Boehringer Ingelheim Vetmedica Gmbh |
Ehv con ul18 y/o ul8 inactivados
|
JP7162072B2
(ja)
|
2018-03-26 |
2022-10-27 |
ベーリンガー インゲルハイム アニマル ヘルス ユーエスエイ インコーポレイテッド |
免疫原性組成物を製造する方法
|
CN112867506A
(zh)
|
2018-09-20 |
2021-05-28 |
勃林格殷格翰动物保健有限公司 |
抗猪流行性腹泻的鼻内载体疫苗
|
EP3852797A1
(en)
|
2018-09-20 |
2021-07-28 |
Boehringer Ingelheim Vetmedica GmbH |
Modified pedv spike protein
|
EP4100420A1
(en)
|
2020-02-06 |
2022-12-14 |
Boehringer Ingelheim Vetmedica GmbH |
Polypeptides useful for detecting anti-rhabdovirus antibodies
|
WO2022076977A1
(en)
|
2020-10-05 |
2022-04-14 |
Boehringer Ingelheim Animal Health USA Inc. |
Fusion protein comprising circoviridae capsid protein, and chimeric virus-like particles composed thereof
|
WO2022076979A1
(en)
|
2020-10-05 |
2022-04-14 |
Boehringer Ingelheim Vetmedica Gmbh |
Fusion protein useful for vaccination against rotavirus
|
US20240050555A1
(en)
|
2022-04-05 |
2024-02-15 |
Boehringer Ingelheim Vetmedica Gmbh |
Immunogenic composition useful for vaccination against rotavirus
|